Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Polymorphic Markers for Genetic Analyses
Schumm, James W.
Promega Corporation, Madison, WI, United States
Search 3 grants from James Schumm
Search grants from Promega Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Osteoporotic Fractures in Men (MrOS) - San Francisco Coordinating Center
SAG E3 ubiquitin ligase in regulation of transformation and carcinogenesis
The population genetics of antibiotic resistance in multi-drug environments
Accuracy of Physical Activity Measures in Cancer Studies
Molecular Studies of Fc Receptors for Immunoglobulin E
Recently added grants:
Natural audiovisual speech encoding in the early stages of the human cortical hierarchy
Odor Blocking of Stress
Early Communication Intervention for Toddlers with Hearing Loss
A20 Mediated Regulation of Colitis and Spondyloarthritis
Role of I-BAR proteins in enterocyte differentiation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44MH052940-02
Application #
2252922
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (12))
Project Start
1994-09-30
Project End
1998-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Promega Corporation
Department
Type
DUNS #
City
Madison
State
WI
Country
United States
Zip Code
53711
Related projects
NIH 1997
R44 MH
Novel Polymorphic Markers for Genetic Analyses
Schumm, James W. / Promega Corporation
NIH 1996
R44 MH
Novel Polymorphic Markers for Genetic Analyses
Schumm, James W. / Promega Corporation
Comments
Be the first to comment on James Schumm's grant